Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 1 / Phase 22026-09-11NCT05520567

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Astellas Pharma Global Development, Inc.43

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of Hope Nat'l Medical CenterDuarteUnited States2
Johns Hopkins UniversityBaltimoreUnited States150
Memorial Cancer InstitutePembroke PinesUnited States4
Motefiore-Einstein Center for Cancer CareThe BronxUnited States1
Novant HealthWinston-SalemUnited States8
Ohio State UniversityColumbusUnited States169
Oregon Health and Science UniversityPortlandUnited States382
Robert H. Lurie Comprehensive Cancer CenterChicagoUnited States1
Roswell Park Cancer InstituteBuffaloUnited States382
Sarah Cannon Research InstituteDenverUnited States16
The University of Texas MDHoustonUnited States1
Thomas Jefferson University HospitalPhiladelphiaUnited States271
UCLA Medical CenterLos AngelesUnited States42
Univ. of California - IrvineIrvineUnited States1
University of ChicagoChicagoUnited States312
University of MarylandBaltimoreUnited States86
University of Pennsylvania-Abramson CCC-Dept. of Hem OncPhiladelphiaUnited States1
Weill Cornell Medical CollegeNew YorkUnited States58